Department of Cellular and Molecular Pharmacology, University of California, San Francisco, 94158, United States.
ACS Chem Biol. 2012 Jan 20;7(1):64-72. doi: 10.1021/cb200418f. Epub 2011 Dec 30.
The continued ability to treat bacterial infections requires effective antibiotics. The development of new therapeutics is guided by knowledge of the mechanisms of action of and resistance to these antibiotics. Continued efforts to understand and counteract antibiotic resistance mechanisms at a molecular level have the potential to direct development of new therapeutic strategies in addition to providing insight into the underlying biochemical functions impacted by antibiotics. The interaction of antibiotics with the peptidyltransferase center and adjacent exit tunnel within the bacterial ribosome is the predominant mechanism by which antibiotics impede translation, thus stalling growth. Resistance enzymes catalyze the chemical modification of the RNA that composes these functional regions, leading to diminished binding of antibiotics. This review discusses recent advances in the elucidation of chemical mechanisms underlying resistance and driving the development of new antibiotics.
为了继续有效治疗细菌感染,我们需要使用有效的抗生素。这些抗生素的作用机制和耐药机制为新疗法的开发提供了指导。深入了解和对抗抗生素耐药机制在分子水平上的作用,除了深入了解抗生素影响的潜在生化功能外,还有可能指导新治疗策略的开发。抗生素与细菌核糖体的肽基转移酶中心和相邻的出口隧道相互作用,是抗生素抑制翻译、阻止生长的主要机制。耐药酶催化组成这些功能区域的 RNA 的化学修饰,导致抗生素的结合减少。本文综述了近年来对抗生素耐药性的化学机制的阐明和新型抗生素的开发所取得的进展。